Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T.W. Chan
Survival Outcomes, Prostate-Specific Antigen (PSA) Response, and Tolerance in First and Later Lines of Enzalutamide Treatment for Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Real-World Experience in Hong Kong
Clinical Genitourinary Cancer
Oncology
Urology
Related publications
Initial Experience of the Enzalutamide Treatment for Castration-Resistant Prostate Cancer
Japanese Journal of Urology
Urology
Prostate-Specific Membrane Antigen–Directed Therapy for Metastatic Castration-Resistant Prostate Cancer
Cancer Journal
Cancer Research
Oncology
Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
Clinical Medicine Insights: Oncology
Oncology
Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy
Klinicka Onkologie
Oncology
A Phase II Trial of Prostate-Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC) in Taxane-Refractory Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Influence of Enzalutamide on Cabazitaxel Pharmacokinetics; A Drug-Drug Interaction Study in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients
Clinical Cancer Research
Cancer Research
Oncology
Prostate-Specific Antigen Decline After 4 Weeks of Treatment With Abiraterone Acetate and Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer
European Urology
Urology
Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Radiotherapy in Metastatic Castration Resistant Prostate Cancer Patients With Oligo-Progression During Abiraterone-Enzalutamide Treatment: A Mono-Institutional Experience
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
